CRVL Fundamental Analysis - CORVEL CORP

Fundamental Rating

CRVL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. CRVL gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, CRVL is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CRVL was profitable.

In the past year CRVL had a positive cash flow from operations.

CRVL had positive earnings in each of the past 5 years.

CRVL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CRVL has a better Return On Assets (16.88%) than 99.01% of its industry peers.

CRVL has a better Return On Equity (29.43%) than 94.06% of its industry peers.

The Return On Invested Capital of CRVL (28.10%) is better than 98.02% of its industry peers.

CRVL had an Average Return On Invested Capital over the past 3 years of 28.60%. This is significantly above the industry average of 9.19%.

		Industry Rank	Sector Rank
ROA	16.88%
ROE	29.43%
ROIC	28.1%

ROA(3y)17.02%

ROA(5y)15.59%

ROE(3y)31.06%

ROE(5y)29.09%

ROIC(3y)28.6%

ROIC(5y)26.25%

1.3 Margins

Looking at the Profit Margin, with a value of 10.98%, CRVL belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.

CRVL's Profit Margin has improved in the last couple of years.

CRVL has a better Operating Margin (13.94%) than 84.16% of its industry peers.

CRVL's Operating Margin has improved in the last couple of years.

CRVL's Gross Margin of 23.79% is in line compared to the rest of the industry. CRVL outperforms 49.51% of its industry peers.

In the last couple of years the Gross Margin of CRVL has grown nicely.

		Industry Rank	Sector Rank
OM	13.94%
PM (TTM)	10.98%
GM	23.79%

OM growth 3Y1.04%

OM growth 5Y5.65%

PM growth 3Y1.12%

PM growth 5Y5.84%

GM growth 3Y-0.17%

GM growth 5Y1.95%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.

The number of shares outstanding for CRVL remains at a similar level compared to 1 year ago.

Compared to 5 years ago, CRVL has less shares outstanding

CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CRVL has an Altman-Z score of 14.30. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.

The Altman-Z score of CRVL (14.30) is better than 97.03% of its industry peers.

There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	14.3

ROIC/WACC3.18

WACC8.84%

2.3 Liquidity

A Current Ratio of 1.79 indicates that CRVL should not have too much problems paying its short term obligations.

CRVL's Current ratio of 1.79 is fine compared to the rest of the industry. CRVL outperforms 64.36% of its industry peers.

A Quick Ratio of 1.79 indicates that CRVL should not have too much problems paying its short term obligations.

CRVL has a Quick ratio of 1.79. This is in the better half of the industry: CRVL outperforms 65.35% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.79
Quick Ratio	1.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.39% over the past year.

The Earnings Per Share has been growing by 16.86% on average over the past years. This is quite good.

Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 12.46% in the last year.

CRVL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.62% yearly.

EPS 1Y (TTM)30.39%

EPS 3Y14.48%

EPS 5Y16.86%

EPS Q2Q%27.95%

Revenue 1Y (TTM)12.46%

Revenue growth 3Y11.49%

Revenue growth 5Y8.62%

Sales Q2Q%10.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 40.75, the valuation of CRVL can be described as expensive.

Compared to the rest of the industry, the Price/Earnings ratio of CRVL is on the same level as its industry peers.

CRVL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.54.

		Industry Rank	Sector Rank
PE	40.75
Fwd PE	N/A

4.2 Price Multiples

CRVL's Enterprise Value to EBITDA is on the same level as the industry average.

The rest of the industry has a similar Price/Free Cash Flow ratio as CRVL.

		Industry Rank	Sector Rank
P/FCF	41.03
EV/EBITDA	24.19

4.3 Compensation for Growth

CRVL has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)2.42

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CRVL does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CORVEL CORP

NASDAQ:CRVL (9/26/2025, 8:00:00 PM)

After market: 78.64 0 (0%)

78.64

+0.23 (+0.29%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)07-28 2025-07-28

Earnings (Next)11-03 2025-11-03

Inst Owners54.46%

Inst Owner Change-2.16%

Ins Owners7.1%

Ins Owner Change-0.67%

Market Cap4.04B

Analysts0

Price TargetN/A

Short Float %2.09%

Short Ratio3.76

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	40.75
Fwd PE	N/A
P/S	4.39
P/FCF	41.03
P/OCF	28.44
P/B	11.78
P/tB	13.22
EV/EBITDA	24.19

EPS(TTM)1.93

EY2.45%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.92

FCFY2.44%

OCF(TTM)2.77

OCFY3.52%

SpS17.9

BVpS6.68

TBVpS5.95

PEG (NY)N/A

PEG (5Y)2.42

Profitability

		Industry Rank	Sector Rank
ROA	16.88%
ROE	29.43%
ROCE	35.36%
ROIC	28.1%
ROICexc	63.53%
ROICexgc	82.75%
OM	13.94%
PM (TTM)	10.98%
GM	23.79%
FCFM	10.71%

ROA(3y)17.02%

ROA(5y)15.59%

ROE(3y)31.06%

ROE(5y)29.09%

ROIC(3y)28.6%

ROIC(5y)26.25%

ROICexc(3y)48.46%

ROICexc(5y)45.93%

ROICexgc(3y)62.9%

ROICexgc(5y)61.44%

ROCE(3y)35.98%

ROCE(5y)33.03%

ROICexcg growth 3Y4.75%

ROICexcg growth 5Y18.9%

ROICexc growth 3Y6.87%

ROICexc growth 5Y18.29%

OM growth 3Y1.04%

OM growth 5Y5.65%

PM growth 3Y1.12%

PM growth 5Y5.84%

GM growth 3Y-0.17%

GM growth 5Y1.95%

F-Score8

Asset Turnover1.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	143.25%
Cap/Sales	4.74%
Interest Coverage	250
Cash Conversion	89.54%
Profit Quality	97.54%
Current Ratio	1.79
Quick Ratio	1.79
Altman-Z	14.3

F-Score8

WACC8.84%

ROIC/WACC3.18

Cap/Depr(3y)112.41%

Cap/Depr(5y)107.09%

Cap/Sales(3y)3.78%

Cap/Sales(5y)3.81%

Profit Quality(3y)90.78%

Profit Quality(5y)99.01%

High Growth Momentum

Growth

EPS 1Y (TTM)30.39%

EPS 3Y14.48%

EPS 5Y16.86%

EPS Q2Q%27.95%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)12.46%

Revenue growth 3Y11.49%

Revenue growth 5Y8.62%

Sales Q2Q%10.86%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y31.08%

EBIT growth 3Y12.65%

EBIT growth 5Y14.76%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y49.21%

FCF growth 3Y34.78%

FCF growth 5Y13.57%

OCF growth 1Y59.6%

OCF growth 3Y23.73%

OCF growth 5Y9.51%

CORVEL CORP (CRVL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens